ALEXANDRA DILLON: Open Payments
NPI 1265175160 · BETHESDA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,742 in 63 payments from 18 companies in 2025. Trend: 2023 $1,423 · 2024 $1,807 · 2025 $1,742
Food & beverage: $1,734Education: $8
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 8 | $231 |
| Incyte Corporation | 9 | $230 |
| ABBVIE INC. | 9 | $219 |
| GENZYME CORPORATION | 6 | $210 |
| Galderma Laboratories, L.P. | 3 | $207 |
| Organon LLC | 4 | $104 |
| PFIZER INC. | 4 | $99 |
| Arcutis Biotherapeutics, Inc. | 3 | $67 |
| UCB, Inc. | 3 | $66 |
| Lilly USA, LLC | 3 | $62 |
Products named: TREMFYA, OPZELURA, SKYRIZI, DUPIXENT, NEMLUVIO, CIBINQO, VTAMA, Zoryve.
Industry payments across MD — which companies pay providers there.
